Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow up Study to Provide Safety, Performance and Clinical Benefits Data of the Taperloc Complete Stems

NCT04028687 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT04028687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04028687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow up Study to Provide Safety, Performance and Clinical Benefits Data of the Taperloc Complete Stems
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Recruiting
Start date
February 13, 2020
Completion date
February 12, 2032
Enrollment
820 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hip arthritis, hip disease, hip fractures, hip injuries, hip pain chronic